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Corticotropin-releasing hormone (CRH), the principal regulator of the hypothalamus–pituitary–
adrenal (HPA) axis, has been implicated as amediator of stress-induced effects on the reproduc-
tive axis. The role of the specific CRH receptor subtypes in this response is not completely under-
stood. In the current study, we investigated the role of the CRH-R1 receptor on luteinizing
hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL), progesterone (P) and cortico-
sterone (CT) secretion in stress-induced responses under the influence of estrogen (E2).
Estrogen-primed ovariectomized rats (estradiol cypionate, 10 μg sc) received an i.v. administra-
tion of antalarmin (0.1 or 1mg/kg), a selective CRH-R1 antagonist, or vehicle before restraint
stress for 40min. Seven blood samples were collected from two experimental groups (one
from 10:00 h to 14:00 h and the other from 10:00 h to 18:00 h). An increase of plasma LH induced
by restraint acute-stress was followed by alteration of the secretion pattern in the estrogen-
induced afternoon surge. In a similar manner, we observed a suppression of the afternoon
surge in plasma FSH, a delay of E2-induced PRL secretion, and an increase in plasma P and CT.
Antalarmin attenuated stress-induce LH increase, decreased CT and P secretion and blocked
the stress effects on PRL secretion. These findings suggest that CRH-R1 mediates, at least in
part, the restraint stress effects on the HPA, PRL, and reproductive axes.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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Prolactin1. Introduction
Recent publications define stress as a conscious or unconscious
threat to homeostasis, in which the response has a degree of
specificity. The body possesses several homeostatic systems
to maintain the values of physiological variables in acceptable
ranges despite internal and external stressors. A typical feature
of the stress response is the activation of the autonomic ner-
vous system and the hypothalamus–pituitary–adrenal (HPA)Fisiologia, Faculdade de
900, Brazil. Fax: +55 16 36
. Franci).
the Elsevier OA license.axis (Goldstein and Kopin, 2007; Goldstein and McEwen, 2002;
Pacak, 2000).
Exposure to stressful stimuli can lead to a variety of second-
ary effects in the cardiovascular, gastrointestinal, immune, ner-
vous, and reproductive systems (Chrousos, 2009). Luteinizing
hormone (LH) and follicle-stimulating hormone (FSH) are the
gonadotropins that drive follicular development, estrogen (E2)
and progesterone secretion (P), estrous cyclicity, and ovulation.
It is generally accepted that chronic stress is a potent inhibitorMedicina de Ribeirão Preto, Universidade de São Paulo, Avenida
33 0017.
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Nonetheless, acute stress may inhibit or activate the HPG
axis depending on background E2 priming. In this way
under adequate E2 levels acute stressors or acute ACTH treat-
ment could increase LH and FSH secretion and then facilitate
the reproduction. It has been shown that adrenal steroids
mediate this effect (Brann and Mahesh, 1991; Marti and
Armario, 1998). There is substantial evidence for interaction
between ovarian and adrenal steroids to control the gonado-
tropin secretion (Mahesh and Brann, 1992). The secretion of
ACTH and corticosterone (Buckingham et al., 1978) and adre-
nal progesterone (Shaikh and Shaikh, 1975) increases on pro-
estrus afternoon compared to the other days of the estrous
cycle. Adrenalectomy causes irregular cyclicity and a prolonged
period of asynchronic gonadotropin surges that can be reversed
by progesterone replacement (Mann et al., 1975). In addition, it
decreases ovarian follicle development (Peppler and Jacobs,
1976).
The mechanisms through which stressors impact the
hypothalamus–pituitary–gonadal (HPG) axis are becoming
better understood. It is well-established that corticotrophin-
releasing hormone (CRH), the principal factor that drives the
HPA axis during stress, is a potent inhibitor of the gonadotro-
pin-releasing hormone (GnRH) pulse generator. Central admin-
istration of CRH inhibits LH pulses (Rivier and Vale, 1984). In
addition, the suppression of LH secretion by a variety of stressful
stimuli can be reversed by CRH antagonists (Rivier and Rivest,
1991).
The physiological effects of CRH receptors are mediated via
the CRH-R1 and CRH-R2 subtypes, which have a heterogeneous
distribution pattern in the brain and a distinct physiopharma-
cology that suggests differential functional roles (Hillhouse
and Grammatopoulos, 2006). The role of the CRH receptors on
the suppression of the stress-induced LH pulses depends on
the nature of the stressor (Li et al., 2006).
In female rats, E2 is widely accepted to be a hormone that
regulates prolactin (PRL) secretion and increases the number
of lactotrophs (Grattan and Kokay, 2008). Various models of
stress are known to induce hyperprolactinemia, which in turn,
could interfere with reproductive functions, including gonado-
tropin secretion (Freeman et al., 2000). Stress-induced hyper-
prolactinemia appears to be mediated by a central action of
CRH because it can be reversed by a central administration of
a CRH antagonist (Akema et al., 1995); however, the subtype of
the receptor that is being inhibited is still unknown.
Non-peptide selective CRH-R1 receptor antagonists, such as
CP 154,526 (Chen et al., 1997) and antalarmin (Webster et al.,
1996), are useful tools for discovering the role of CRH-R1 receptors
during stress. Antalarmin crosses the blood brain barrier (Habib
et al., 2000) and i.v. injection of this compound decreases the
activity of the HPA axis in experimental models using physical
and behavioral stress (Jutkiewicz et al., 2005; Myers et al., 2005).
Antalarmin blocks the anxiogenic action of CRH in rats, as
showed by studies using an elevated plus maze (Zorrilla et al.,
2002) or impairs the acquisition andmaintenance of conditioned
fear responses (Deak et al., 1999). In nonhuman primates, the i.v.
administration of antalarmin decreases behavioral anxiety re-
sponses, ACTH levels, and cortisol levels (French et al., 2007;
Habib et al., 2000). Thus, antalarmin reduces activity of the HPA
axis and attenuates the fear and anxiety states in animalmodels. However, its effect on the HPG and PRL axes has not
yet been investigated. In summary, considering the evidences
of interaction between ovarian and adrenal steroids to control
the gonadotropin secretion, the effects of stress on HPG axis,
the effects of estrogen and stress on PRL secretion; the present
study was designed to investigate whether the acute restraint
stress effects on the HPA, PRL and HPG axes in estrogen-
primed rats can be reversed by a selective CRF-R1 receptor
antagonist.2. Results
2.1. Effects of acute stress on hormonal secretion in
estrogen-primed rats
The plasma concentrations of LH, PRL, FSH, CT and P obtained
in both experiments are shown in Figs. 1–5, respectively. After
restraint stress the LH secretion increased rapidly to reach a
peak about 30–40 times its initial value keeping this level for
3 h (from 11:00 h to 14:00 h) (F 6,288=4.73, p=0.001) (Fig. 1A).
This increase was followed by a decrease in the afternoon
(Fig. 1B) when the LH secretion normally should be higher due
to the E2 stimulatory effect (F 6,288=6.72, p=<0.0001) with a
final peak at 18:00 h. The CT and P levels increased rapidly and
returned to basal levels at 14:00 h or forward (F 6,288=14.17,
p=<0.0001 and F 6,288=8.15, p=<0.0001 respectively) (Figs. 4, 5).
In the stress group, the increase of PRL secretion was minor at
14:00 h (F 6,288=3.89, p=0.0009) and higher after 16:00 h when
compared with the vehicle non-stress group (F 6,288=8.15,
p=<0.0001) (Fig. 2). The morning concentrations of FSH were
not affected by the stress procedure (Fig. 3A) (F 6,288=0.95,
p=0.5387). The FSH surge that was induced by E2 at 17:00 h was
not observed in the restraint stress group (Fig. 3B) (F 6,288=2.68,
p=0.0151).
2.2. Effects of antalarmin on hormonal secretion in
estrogen-primed rats
In non-stress conditions, hormonal secretion induced by E2 was
not affected by i.v. antalarmin injection (0.1 or 1mg/kg). Statisti-
cal analysis revealed that vehicle, antalarmin 0.1 mg/kg and
antalarmin 1mg/kg groups innon-stress conditionswerenot dif-
ferent among them (LH F 2,126=0.31, p=0.7338; CT F 2,126=0.31,
p=0.7338; PRL F 2,126=0.46, p=0.6323; P=F 2,126=1.04, p=0.3574;
FSH F 2,126=0.26, p=0.6103). Table 1 shows non-stress mean
values in every collected time of all hormones studied.
The intravenous administration of the CRH-R1 specific antag-
onist (antalarmin, 1 and 0.1 mg/kg) 20 min before the onset of
the restraint stress significantly attenuated the stimulatory ef-
fect of this stress on LH secretion during the time period from
11:00 h to 14:00 h (F 2,288=7.51, p=0.0007) (Fig. 1A). However, the
LH surge alteration induced by stress was not modified by anta-
larmin (Fig. 1B) (F 12,288=1.44, p=0.1462). The CRH-R1 antagonist
decreased the CT and P secretion induced by restraint stress
(F 12,288=1.80, p=0.048 and F 2,288=4.85, p=0.0085 respectively)
(Figs. 4, 5). In addition, this antagonist blocked the PRL secre-
tion alterations induced by stress (F 12,288=2.06, p=0.0197)
(Fig. 2). The administration of a CRH-R1 antagonist did not
Fig. 1 – Effects of restraint stress (40 min) on luteinizing
hormone (LH) secretion in estrogen-primed ovariectomized
rats previously treatedwith antalarmin (0.1 or 1 mg/kg i.v.) or
vehicle. As control, a group no-stress was treated with
vehicle. A (from 10 to 14 h) and B (from 10 to 18 h). Data are
shown as mean±SEM and were analyzed using a Mixed
Linear Model. Significant differences: * stress vs. antalarmin
and the control vehicle groups (p<0.001); † control vehicle vs.
antalarmin (p<0.05); # control vehicle vs. stress and the
antalarmin groups (p<0.05). Group size=10 animals.
Fig. 2 – Effects of restraint stress (40 min) on prolactin (PRL)
secretion in estrogen-primed ovariectomized rats previously
treated with antalarmin (0.1 or 1 mg/kg i.v.) or vehicle. As
control, a group no-stress was treated with vehicle. A (from
10 to 14 h) and B (from 10 to 18 h). Data are shown as mean±
SEM and were analyzed using a Mixed Linear Model.
Significant differences: *stress vs. antalarmin and the control
vehicle groups (p<0.05); † control vehicle vs. antalarmin
groups (p<0.05). Group size=10 animals.
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17:00 h (F 12,288=0.51, p=0.9051).3. DiscussionOur results showed, for the first time, that CRH-R1 plays a key
role in the stress-induced stimulatory effects on LH secretion.
Peripheral administration of the selective CRH-R1 antagonist,
antalarmin, attenuated the restraint stress-induced increase of
LH secretion in E2-primed ovariectomized rats. In addition, we
showed for the first time that the effects of restraint stress on
P and PRL secretion are mediated, at least in part, by CRH-R1.
Antalarmin decreased the P secretion and biphasic PRL pattern
induced by restraint stress when compared with control group.
Although it is well established that chronic stress exerts an
inhibitory action on the HPG axis at central or peripheral levels
(Rivier and Rivest, 1991), there is little information about which
mechanisms are involved in the acute stress effects on the HPG
axis. Previous studies in female rats (Briski and Sylvester, 1988;
Kam et al., 2000), pigs (Einarsson et al., 2008), non-humanprimates (Xiao et al., 1994), humans (Puder et al., 2000) and a re-
cent review about acute stress and ovulation, pointed out that
positive responses of the HPG axis are found under relatively
high plasma levels of E2 (Tarin et al., 2010). The researchers ob-
served that acute stressors applied for rats on the morning of
proestrus, E2-treated female rats, Rhesusmonkeys during the
mid-follicular and mid-luteal phases or women during the
mid-follicular phase can facilitate LH secretion and conse-
quently the ovulation. Our study extends this information
showing that restraint stress for 40 min initially causes a
stimulation of the HPG axis, which is followed by decreased
pattern of secretion of LH induced normally by E2 replace-
ment. Afternoon plasma LH levels only reach a peak at the end
of the experiment. Our experimental design do not allow to con-
clude if LH surgewas delayed completely or partially inhibited by
restraint stress, because we withdrew blood samples until
1800 h. These timing-effects may be related to the duration
of the exposure to a stressor because continuous restraint
stress abolishes the normal LH secretion (Kam et al., 2000).
Nonetheless, the stress-induced stimulatory effect on the LH
secretion depends on CRH-R1 antagonism. Other researchers
have shown that CRH receptors have different participation in
Fig. 3 – Effects of restraint stress (40 min) on follicle
stimulating hormone (FSH) secretion in estrogen-primed
ovariectomized rats previously treated with antalarmin (0.1
or 1 mg/kg i.v.) or vehicle. As control, a group no-stress was
treated with vehicle. A (from 10 to 14 h) and B (from 10 to
18 h). Data are shown as mean±SEM and were analyzed
using a Mixed Linear Model. Significant differences: * stress
vs. antalarmin and the control vehicle groups (p<0.05). Group
size=10 animals.
Fig. 4 – Effects of restraint stress (40 min) on corticosterone
(CT) secretion in estrogen-primed ovariectomized rats
previously treated with antalarmin (0.1 or 1 mg/kg i.v.) or
vehicle. As control, a group no-stress was treated with
vehicle. A (from 10 to 14 h) and B (from 10 to 18 h). Data are
shown as mean±SEM and were analyzed using a Mixed
Linear Model. Significant differences: * stress vs. antalarmin
and the control vehicle groups (p<0.001); †control vehicle vs.
antalarmin groups (p<0.05). Group size=10 animals.
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mediates the response to restraint stress, whereas CRH-R2 me-
diates the response to hypoglycemia and immunological stress
(Li et al., 2005, 2006). Therefore, the stress-induced LH surge
modification in our animals may have been mediated by CRH-
R2 rather than CRH-R1. In fact, data from our laboratory (yet
unpublished) support this hypothesis.
Studies that used the swing-forced test model have reported
that antalarminmodulates the CRH receptors in the locus coeru-
leus (LC) (Reyeset al., 2008). TheLC, oneof theprincipal sourcesof
noradrenaline in the brain, is highly responsive to stress (Conti
et al., 1997). It exerts a key role on LH secretion (Anselmo-Franci
et al., 1997), expresses CRH-R1 receptors (Sauvage and Steckler,
2001) and projects to the medial preoptic area (MPOA) (Campbell
and Herbison, 2007), where a subpopulation of GnRH neurons
is activated by noradrenaline in presence of E2 (Etgen, 2003;
Herbison, 1997). Thus, our laboratory is currently testing the
hypothesis that antalarmin attenuates the stress-induced LH
secretion due to a direct antagonism of the CRH-R1 receptors
innoradrenergic LC neurons. The E2-induced FSH and LHsurges
that occur at afternoon are altered by restraint stress. The effect
of suppression on gonadotropin secretion has been reportedearlier in E2-primed ovariectomized rats (Briski and Sylvester,
1988; Kam et al., 2000) submitted to different acute stressors
and in cycling rats under restraint stress by 5 h (Roozendaal
et al., 1995). There are strong evidences that chronic stress in-
hibits the HPG axis activity via HPA axis. The mechanisms for
this response include direct (Dudas and Merchenthaler, 2002;
MacLusky et al., 1988) and indirect inhibitory projections from
CRH neurons to GnRH neurons (Rivest et al., 1993). Moreover,
the released glucocorticoids act at three different levels: 1) hy-
pothalamus, on synthesis and release of GnRH; 2) pituitary, de-
creasing the synthesis and release of LH and FSH; 3) gonad,
hindering the stimulatory effect of the gonadotropins on ste-
roidogenesis; (Breen and Karsch, 2004; Kalantaridou et al.,
2004; Rivier and Rivest, 1991).
It is generally accepted that chronic stress is a potent inhib-
itor of reproductive function (Wingfield and Sapolsky, 2003).
The organisms are prepared to inhibit reproductive function
and mobilize the energy to vital systems during chronic stress.
On the other hand, the facilitation of HPG axis activity during
acute stress is not so obvious. Coitus-induced preovulatory LH
surge has been characterized in several species (for instance,
rabbits, voles, cats, ferrets and camels) in contrast with other
Fig. 5 – Effects of restraint stress (40 min) on progesterone (P)
secretion in estrogen-primed ovariectomized rats previously
treated with antalarmin (0.1 or 1 mg/kg i.v.) or vehicle. As
control, a group no-stress was treated with vehicle. A (from
10 to 14 h) and B (from 10 to 18 h). Data are shown as mean±
SEM and were analyzed using the Mixed Linear Model.
Significant differences: *stress vs. antalarmin and the control
vehicle groups (p<0.05); # stress vs. antalarmin groups
(p<0.05). † Control vehicle vs. antalarmin groups (p<0.05).
Group size=10 animals.
15B R A I N R E S E A R C H 1 4 2 1 ( 2 0 1 1 ) 1 1 – 1 9species that present spontaneous ovulation (rats, sheep, mon-
keys and humans). The exceptional occurrence of induced ovu-
lation in these later animals hasmotivated the hypothesis that
induced ovulation is a primitive characteristic from which
evolved the spontaneous ovulation (Jochle, 1975). Mammalian
species including human can show reproductive facilitation
under specific occasions (see review Bakker and Baum, 2000).
Interestingly, our study showed difference between FSH and
LH secretion in response to stress in the morning. This differ-
ence was documented decades ago after the use of several ani-
mal models (Du et al., 1979; McCann et al., 1983) and more
recently during the evaluation of the gonadotropins secretion
in ewes (Padmanabhan et al., 2003) or after CT treatment in
male and female rats (Gore et al., 2006). These results support
the existence of independent control systems that drive the
FSH- and LH-induced stress responses. Our data indicate that
there is a dissociation of the mechanisms for the secretion of
FSH and LH in response to restraint stress in the morning but
not in the afternoon. The role of this dissociation is not yet
clear and it will depend on other studies.
PRL secretion is greatly altered by a large number of stressful
stimuli (Freeman et al., 2000). Stress increases PRL secretion
when its levels are near basal and decreases the PRL levelswhen they are already elevated (Gala, 1990). In our study, the
E2-induced PRL surge was delayed by acute restraint stress.
This effect was blocked by the administration of antalarmin, in-
dicating that CRH may mediate this response through CRH-R1.
PRL secretion is predominantly under the tonic inhibitory
control of hypothalamic dopamine, which is the primary
PRL inhibiting factor (Ben-Jonathan and Hnasko, 2001). Data
from other laboratories have shown that the inhibition of PRL
secretion during immobilization stress is correlated with an in-
crease in dopamine D2 receptors in the pituitary gland (Kam et
al., 2000). It has also been shown that antalarmin reversed
the up-regulation of dopamine D2 receptors in the amygdala
andnucleus accumbens (Djoumaet al., 2006) of animals exposed
to the social isolation stress. Taken together, these data suggest
that CRH may modulate the dopaminergic system through
CRH-R1 to control PRL secretion that is induced by acute stress.
Classic physiological validation of the restraint stress pro-
cedure was provided by the activation of HPA axis, which was
evidenced by the increases of CT and P secretion in our animals.
The basal and post-stress CT concentrationswere similar to the
data from femalemodels that used E2-priming (Figueiredo et al.,
2007; Kam et al., 2000). The decrease of the plasma CT and cor-
tisol induced by antalarmin has been reported extensively for
stress models used in rodents (Jaszberenyi et al., 2007; Myers
et al., 2005) and in non-human primate (French et al., 2007;
Habib et al., 2000).
Our data showed that antalarmin administration attenuat-
ed but did not block CT secretion which is possibly seen that
this secretion seems also dependent on CRH-R2. Previous
studies have shown that CRH-R1 and CRH-R2 receptors exert
complementary functions during the stress response (Bale
et al., 2002). Both CRH receptors have been shown to partici-
pate in this response but in different forms, CRH-R1 has been
shown to be fundamental to the onset of the stress response
(Preil et al., 2001), meanwhile CRH-R2 has been involved in
the recovery response (de Kloet et al., 2005).
In a similar manner to the CT response, stress-induced P se-
cretion was attenuated by antalarmin. This stress response has
been reported in male rats exposed to metabolic (Elman and
Breier, 1997), restraint (Jaroenporn et al., 2007), or electroshock
stressors (Andersen et al., 2004). This stress response has also
been reported in female rats exposed to ether inhalation (Deis
et al., 1989) and in ovariectomized monkeys replaced with E2
subjected to immunological stress (Xiao et al., 1994). Our results
provide new evidence about the partial involvement of CRH-R1
receptors in this stress response.
It has been shown that P secretion increases in response to
stressors in cyclic (Boehm et al., 1982) and ovariectomized
(Budec et al., 2002) female rats. Stress-induced progesterone se-
cretion can bemediated solely by adrenal glandwhereas occurs
in ovariectomized prepubertal and adult female rats. Puberty in
female is associated with changes of function and reactivity in
the hypothalamus–pituitary–adrenal (HPA) axis (Romeo et al.,
2004). Progesteronehas a biphasic effect on gonadotropin secre-
tion (Everett, 1948). It plays an important role in synchronizing
and potentiating the preovulatory gonadotropin surge, ensur-
ging a full ovulatory quota ova and limiting the gonadotropin
surge toproestrus day (BrannandMahesh, 1991). It has beenhy-
pothesized that adrenal P plays a stimulatory and ovarian P
plays an inhibitory action on gonadotropin secretion (Mahesh
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16 B R A I N R E S E A R C H 1 4 2 1 ( 2 0 1 1 ) 1 1 – 1 9and Brann, 1992). The alteration of gonadotropin secretion that
we observed with antalarmin administration may be mediated
by decreasing of P secretion.
In summary, acute restraint stress modifies differently the
pattern secretion of LH, PRL, FSH, CT and P in E2 replaced
ovariectomized rats. The secretion of LH, CT and P changes
rapidly after the end of stress. However, the secretion of PRL
and FSH occurs some hours later. This work shows that,
CRH-R1 antagonist reverses totally the increased secretion of
LH and the delay of PRL secretion, but partially the increased
secretion of CT and P. The effect on the FSH surge remains
unchanged with administration of CRH-R1 antagonist. The
present study provides evidence that CRH-R1 mediates, at
least in part, hormonal alterations induced by acute stress.
The anatomical sites that are responsible for these responses
have not yet been identified.4. Experimental procedures
Wistar adult female rats,weighing 200–220 g,were obtained from
the animal house of the University of São Paulo at Ribeirão Preto
and were kept in a central animal-care facility. These animals
were housed in groups of five in plastic cages (50×32×17 cm)
under a 12:12 h light⁄dark cycle (lights on at 06:00 h) and con-
trolled temperature (22±0.5 °C). The air exchange rate in the ani-
mal housewas ten-roomvolumes per hour. Food andwaterwere
provided ad libitum. Vaginal smears were taken daily and the
surgical procedureswere carried out during themetaestrus or di-
estrus phase. All of the protocols were followed in accordance
with the National Institutes of Health Guidelines for the Care
and Use of Laboratory Animals (USA) and approved by the Ethics
Committee in Animal Research of the Medical School of Ribeirão
Preto, University of São Paulo.
4.1. Experimental protocols
The rats were bilaterally ovariectomized under ketamine
and xylazine anesthesia (100:20 mg/kg i.p. Agener®, Brazil
and Dopaser®, Spain). After surgery, all of the rats were trea-
ted with a prophylactic dose of antibiotic (Pentabiotic®, Fort
Dodge, Campinas, Brazil; 0.1 ml/rat) and the analgesic flunixin
meglumine (2.5 mg/kg i.m., Banamine®, Schering-Plough, Rio
de Janeiro, Brazil). The animalswere primedwith estradiol cypio-
nate (10 μg/0.1 ml, s.c., Pfizer, Paulinia-SP, Brazil) at 10:00 h for 3
consecutive days, starting on the 5th day after the ovariectomy,
which resembled hormonal secretion like to the proestrus
phase. One day before the experiment, on the 7th day after the
ovariectomy, a catheter (with an inner diameter of 0.51 mm
and an outer diameter of 1.96 mm, Silastic® Dow Corning Co.,
Midland, Michigan, USA) filled with sterile saline (0.9% NaCl)
was inserted through the external jugular vein into the right
atrium, according to previously described technique, (Harms
and Ojeda, 1974) under tribromoethanol anesthesia (1 ml/100 g
body wt, i.p., 2.5% solution, Sigma-Aldrich, Milwaukee, USA).
4.1.1. Experiment 1
4.1.1.1. Antalarmin effects on hormonal secretion on the morning
after restraint stress in estrogen-primed rats. The animals were
17B R A I N R E S E A R C H 1 4 2 1 ( 2 0 1 1 ) 1 1 – 1 9kept in individual cages and an extension of tubing PE-50 filled
with sterile heparinized saline (150 I.U. heparin/ml) was con-
nected to the jugular catheter, at 9:30 h approximately. The
catheter was washed with the saline solution and the rats
were left undisturbed in their cages for 30min before the begin-
ning of the experiment. At 10:00 h, a basal blood sample was
collected and immediately the rats received either antalarmin
(1 or 0.1 mg/kg i.v. Sigma-Aldrich, Steinheim, Germany) or vehi-
cle (9% ethanol, 9% emulphor and 82% sterile water) (Broadbear
et al., 2002). Twenty minutes later the animals were submit-
ted to restraint procedure that consisted of keep up them
for 40 min in cylindrical plastic tubes (21 cm in length×6 cm
in diameter) with holes to allow access to fresh air. Seven
blood samples (0.5 ml each) were collected through the jugu-
lar catheter from 10:00 until 14:00 h (10:00; 11:00; 11:15; 11:30;
12:00; 13:00 and 14:00 h). The volume withdrawn was imme-
diately replaced with saline. The blood samples were centri-
fuged at 1200×g for 15min at 4 °C, and the plasma was
separated and stored at −20 °C until the measure of hormone
levels by radioimmunoassay (RIA). The controls were left to
roam freely around their enclosure following the injection of ve-
hicle or antalarmin (1 or 0.1 mg/kg i.v.).
4.1.2. Experiment 2
4.1.2.1. Antalarmin effects on hormonal secretion during the
afternoon after restraint stress in estrogen-primed rats. The
same procedures described for Experiment 1 were also used in
this; however, the blood samples were withdrawn from 10:00
to 18:00 h (10:00; 11:00; 14:00; 15:00; 16:00; 17:00 and 18:00 h).
4.2. Radioimmunoassay
The plasma concentrations of LH, FSH, and PRLwere determined
by double antibody RIA with specific antibodies provided by the
National Hormone and Peptide Program (Harbor-UCLA Medical
Center, USA). The iodinated hormones and the secondary anti-
body were produced by Dr. Franci's Laboratory (Medical School
of Riberião Preto, University of São Paulo, Brazil). All of the sam-
ples were assayed in the same RIA. The lower limits of detection
were 0.05 ng/ml for LH, 0.2 ng/ml for FSH, and 0.09 ng/ml for PRL.
The intra-assay coefficients of variation for LH, FSH, and PRL
were 4%, 3%, and 3.5%, respectively. The corticosterone-RIA
used a specific antibody and standard from Sigma (St. Louis,
MO, USA) and H3− corticosterone from Amersham (Piscataway,
NJ, USA). The lower limit of detection was 0.08 ng/ml, and the
intra-assay and inter-assay variation coefficients were 4.5 and
11.4%, respectively. Plasma progesterone was determined by
RIA using the Biochem ImmunoSystems MAIA® kit (Italy). All of
the samples were assayed in the same assay. The lower limit of
detectionwas 1.2 ng/ml and the intra-assay coefficient was 2.5%.
4.3. Statistical analysis
All of the data are presented as the mean±standard error of
mean (SEM). In both experiments each hormonewas analyzed
separately with three independent variables (stress, drug, and
collection time). These multivariate analyses were performed
using a Mixed Linear Model (fixed and random effects) be-
cause repeated observations were taken for each animal(Schall, 1991). All statistical analyses were carried out using
SAS (v.9.1, SAS, Cary, NC, USA), with the proc GLM and proc
Mixed. The significance level was defined at 5%.Acknowledgments
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